# C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

> **NCT04099797** · PHASE1 · RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 56 (estimated)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma
- High Grade Glioma
- Embryonal Tumor
- Ependymal Tumor

## Interventions

- **GENETIC:** C7R-GD2.CART cells (IV and ICV infusion)
- **GENETIC:** C7R-GD2.CART cells (IV and ICV infusion)

## Key facts

- **NCT ID:** NCT04099797
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-03
- **Primary completion:** 2027-02
- **Final completion:** 2041-02
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04099797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04099797, "C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04099797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*